258 related articles for article (PubMed ID: 12697433)
1. Progressive dystonia in a 12-year-old boy.
Klepper J; Schaper J; Raca G; Coryell J; Das S; Hayflick SJ; Voit T
Eur J Paediatr Neurol; 2003; 7(2):85-8. PubMed ID: 12697433
[TBL] [Abstract][Full Text] [Related]
2. The first Vietnamese patient who presented late onset of pantothenate kinase-associated neurodegeneration diagnosed by whole exome sequencing: A case report.
Tran VK; Vu CD; Tran HA; Lien NTK; Tung NV; Lan NN; Tran HT; Hoang NH
Medicine (Baltimore); 2023 Oct; 102(43):e34853. PubMed ID: 37904482
[TBL] [Abstract][Full Text] [Related]
3. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
Hayflick SJ; Westaway SK; Levinson B; Zhou B; Johnson MA; Ching KH; Gitschier J
N Engl J Med; 2003 Jan; 348(1):33-40. PubMed ID: 12510040
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.
Hayflick SJ
Curr Opin Pediatr; 2003 Dec; 15(6):572-7. PubMed ID: 14631201
[TBL] [Abstract][Full Text] [Related]
5. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic features of PKAN patients in a tertiary centre in Turkey.
Akcakaya NH; Iseri SU; Bilir B; Battaloglu E; Tekturk P; Gultekin M; Akar G; Yigiter R; Hanagasi H; Alp R; Cagirici S; Eraksoy M; Ozbek U; Yapici Z
Clin Neurol Neurosurg; 2017 Mar; 154():34-42. PubMed ID: 28113101
[TBL] [Abstract][Full Text] [Related]
7. Novel PANK2 mutation discovered among South East Asian children living in Thailand affected with pantothenate kinase associated neurodegeneration.
Sakpichaisakul K; Saengow VE; Suwanpratheep P; Rongnoparat K; Panthan B; Trachoo O
J Clin Neurosci; 2019 Aug; 66():187-190. PubMed ID: 31088771
[TBL] [Abstract][Full Text] [Related]
8. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic basal ganglia calcifications: an atypical presentation of PKAN.
Wu YW; Hess CP; Singhal NS; Groden C; Toro C
Pediatr Neurol; 2013 Nov; 49(5):351-4. PubMed ID: 23968566
[TBL] [Abstract][Full Text] [Related]
10. Clinical, imaging and genetic profile of twenty-four patients with pantothenate kinase-associated neurodegeneration (PKAN)- A single centre study from India.
Sriram N; Holla VV; Kumari R; Kamble N; Saini J; Mahale R; Netravathi M; Padmanabha H; Gowda VK; Battu R; Pandey A; Yadav R; Muthusamy B; Pal PK
Parkinsonism Relat Disord; 2023 Jun; 111():105409. PubMed ID: 37121191
[TBL] [Abstract][Full Text] [Related]
11. A novel gene mutation in PANK2 in a patient with an atypical form of pantothenate kinase-associated neurodegeneration.
Pérez-González EA; Chacón-Camacho OF; Arteaga-Vázquez J; Zenteno JC; Mutchinick OM
Eur J Med Genet; 2013 Nov; 56(11):606-8. PubMed ID: 24075960
[TBL] [Abstract][Full Text] [Related]
12. CLINICAL EFFECT OF A MUTATION (p.Glu322Asp, c.966 G>T) IN PANK2 GENE IN A FAMILY WITH ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION.
Ayas ZO; Karkucak M; Ocal RO; Yakut T
Genet Couns; 2016; 27(4):489-494. PubMed ID: 30226968
[TBL] [Abstract][Full Text] [Related]
13. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
[TBL] [Abstract][Full Text] [Related]
14. Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
Doi H; Koyano S; Miyatake S; Matsumoto N; Kameda T; Tomita A; Miyaji Y; Suzuki Y; Sawaishi Y; Kuroiwa Y
J Neurol Sci; 2010 Mar; 290(1-2):172-6. PubMed ID: 20006850
[TBL] [Abstract][Full Text] [Related]
15. Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without 'eye-of-the-tiger' sign on MRI in a pair of siblings.
Zolkipli Z; Dahmoush H; Saunders DE; Chong WK; Surtees R
Pediatr Radiol; 2006 Aug; 36(8):884-6. PubMed ID: 16758184
[TBL] [Abstract][Full Text] [Related]
16. Clinical, imaging, and molecular findings in a sample of Mexican families with pantothenate kinase-associated neurodegeneration.
Morales-Briceño H; Chacón-Camacho OF; Pérez-González EA; Arteaga-Vázquez J; Rodríguez-Violante M; Cervantes-Arriaga A; Pérez-Rodríguez L; Zenteno JC; Mutchinick OM
Clin Genet; 2015 Mar; 87(3):259-65. PubMed ID: 24712887
[TBL] [Abstract][Full Text] [Related]
17. Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome).
Gordon N
Eur J Paediatr Neurol; 2002; 6(5):243-7. PubMed ID: 12374576
[TBL] [Abstract][Full Text] [Related]
18. Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
Zhang YH; Tang BS; Zhao AL; Xia K; Long ZG; Guo JF; Westaway SK; Hayflick SJ
Mov Disord; 2005 Jul; 20(7):819-21. PubMed ID: 15747360
[TBL] [Abstract][Full Text] [Related]
19. Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation.
Rossi D; De Grandis E; Barzaghi C; Mascaretti M; Garavaglia B; Zanotto E; Morana G; Biancheri R
Brain Dev; 2012 Jun; 34(6):536-8. PubMed ID: 21999968
[TBL] [Abstract][Full Text] [Related]
20. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome).
Kapoor S; Hortnagel K; Gogia S; Paul R; Malhotra V; Prakash A
Indian J Pediatr; 2005 Mar; 72(3):261-3. PubMed ID: 15812126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
